Sarah Gheuens, Chief Medical Officer at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 6,604 shares at $43.92 ($290K) on 2025-10-27, disclosed to the SEC on 2025-10-29.
Scheduled sale ($290k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.92 | 3,302 | $145K | 50.0% |
| 2 | $43.92 | 3,302 | $145K | 50.0% |
| Total | $43.92 avg | 6,604 | $290K | 100% |
| Filing → |
| AGIO | SELL | 2026-04-06 | $102K | — | Filing → |
| AGIO | SELL | 2026-03-03 | $83K | — | Filing → |
| AGIO | SELL | 2026-01-02 | $79K | — | Filing → |